None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Male subjects in general good health with scalp conditions (Dry, Itchy, Irritated, Redness, Flaking) 2) Subjects in the age group 18-45 years (both ages inclusive). 3) Subjects with moderate flakes. 4) Subjects willing to give written informed consent and willing to abide by and comply with the study protocol. 5) Subjects willing to refrain from using any other product that can impact scalp health.
Exclusion criteria
Exclusion criteria: 1) Subjects having any active scalp disease which may interfere with the study based on the dermatologist s discretion. 2) Subjects who have taken chemotherapy for cancer in the 6 months prior to the start of the study. 3) Subjects who have undergone hair transplants. 4) A known history or present condition of allergic response/hypersensitivity to any hair or pharmaceutical products. 5) Subjects on oral medications like topical or systemic corticosteroids, anti-fungal, or antibiotics, or any prolonged use of non-steroidal anti-inflammatory, or anti-histaminic within 2 weeks prior to the study, undergoing any chemical hair salon treatment-straightening / perming/color/henna which will compromise the study. 6) Subjects participating in other similar trials within the last 2 weeks. 7) Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, thyroid, hepatitis, severe anemia, serious disorder of the heart and respiratory apparatus or any other serious medical illness 8) Employees of MSCR or the sponsor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Improvement of scalp health/condition and significant reduction of the total dandruff score, Non-Adherent and Adherent flakes score evaluated by Visual assessment. 2)Reduction in oiliness and Improved scalp hydration by non-invasive instrumental assessment. 3)Efficacy of the test product in reducing flakes using the Visible Flake Assessment. 4)Change of microbiome of the scalp by product usage at week 4. 5)Improved scalp condition by microscopic imaging. Timepoint: Baseline, week 2 and week 4 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Improved scalp health by Subject self-assessment.Timepoint: Baseline, week 2 and week 4 | — |
Countries
India
Contacts
MS Clinical Research Pvt. Ltd.